Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

BACKGROUND: Classical patient and tumour characteristics are the benchmark of personalised breast cancer (BC) management. Recent evidence has demonstrated that immune and molecular profiling of BC may also play an important role. Despite evidence of differences between invasive ductal (IDC) and lobu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Molecular Diagnostics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119991/
https://ncbi.nlm.nih.gov/pubmed/24937677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.338
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki